Barely Significant
← all phrases

“narrowly missed significance”

113 sentences · 113 papers · 137 search hits before verification · confirmed specimen

Sighted at

p=0.051

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

In another placebo-controlled study in patients with symptom duration of <4 weeks and reduced contrast sensitivity, simvastatin (a hypercholesterolemia medication) narrowly missed significance on the primary efficacy outcome (contrast sensitivity), but improvements were noted for VEP latency and amplitude. 58 However, imbalances in randomization and technical issues may have contributed to the observed effects. 59 A study in ON testing possible neuroprotective effects of phenytoin, an anticonvulsant, has recently completed, and another study testing effects of amiloride hydrochlorothiazide, a diuretic, is currently underway.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
Neurol Neuroimmunol Neuroinflamm · 2015 · PMC4516397
Additional ADME proteins were differentially expressed but narrowly missed significance, namely the ABC transporter ABCA2, alcohol dehydrogenases ADH4 and ADH6, glutathione S-transferases GSTA2 and MGST3, solute carrier organic anion transporter SLCO1B3 , and the superoxide dismutase SOD3 that tended to be reduced, whereas GSTM1 and the solute carrier SLC22A18 tended to be considerably higher (Fig. 2 B; Supplementary Table 1 ).
62 , 75 , 76 In MERIT, which randomized patients from Japan, China, and Russia to monthly mepolizumab, the nasal obstruction improved significantly, while the polyp‐size endpoint narrowly missed significance, mirroring the pattern seen in East Asian population subgroups in ANCHOR. 29 , 74 In parallel to CRSwNP, the subgroup analyses for the SWIFT trials for asthma also suggested lower asthma exacerbation rates in East Asian participants, compared with non‐Asian participants despite identical dosing, underscoring the role of population mix. 77 Hence, no conclusion regarding drug superiority can be drawn from the current trials, due to differences across enrollment mixes.
Specifically, positive attitudes increased, and nonacceptance decreased with higher subjective social status, although the post hoc test between the high and low social status groups for the attitudes subscale narrowly missed significance in the unweighted dataset (refer to Multimedia Appendix 1 ).